Categories Earnings, Retail

L Brands (NYSE: LB) posts a wider loss in Q3 but meets estimates

L Brands Inc. (NYSE: LB) reported a wider loss in the third quarter of 2019 due to higher costs and expenses. The bottom line matched analysts’ expectations while the top line missed consensus estimates. The company guided fourth-quarter earnings above the Street’s view.

Net loss was $252 million or $0.91 per share compared to a loss of $42.75 million or $0.16 per share in the previous year quarter. The results included a charge related to certain Victoria’s Secret store and other assets. Adjusted earnings plunged by 88% to $0.02 per share.

L Brands (LB) Q3 2019 Earnings Review

Revenue declined by 4% to $2.68 billion. Comparable sales declined by 2% for the third quarter and comparable store sales decreased by 3%. This was due to a decline in Victoria’s Secret.

Looking ahead into the fourth quarter, the company expects earnings to be about $2.00 per share. For the full year 2019, the company now expects earnings of about $2.40 per share compared to the previous forecast range of $2.30 to $2.60 per share.

For the third quarter, sales for Victoria’s Secret segment were $1.41 billion, and comp sales decreased 7%, including an 8% decline in store comps, due to declines in traffic and average unit retails. Total digital sales declined by 6%.

Looking into the holiday season, the company is up against aggressive promotional activity from last year. The company will continue to remain agile in reading the business and respond with appropriate promotional activity to drive traffic and manage inventory levels while optimizing its margin dollar result.

Read: Target Q3 earnings review

Sales for the Bath & Body Works segment grew by 11% to $1.064 billion. Comps increased by 9% and store-only comps rose 5%. Sales performance was balanced across the quarter. Customers responded well to its merchandise assortment with all major merchandise categories growing relative to last year.

In the international segment, revenue was about flat to last year at $133.4 million. The company continues to be confident about its prospects for growth in international markets and remains focused on the fundamentals.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top